One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
Ryan B Rush1– 3 1Department of Ophthalmology, Panhandle Eye Group, Amarillo, TX, USA; 2Department of Ophthalmology, Southwest Retina Specialists, Amarillo, TX, USA; 3Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, USACorrespondence: Ryan B Rush, Southwest Retina Spe...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-08-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/one-year-outcomes-of-faricimab-treatment-for-aflibercept-resistant-neo-peer-reviewed-fulltext-article-OPTH |